Skip to content

Global AlcHep – A Worldwide Study on Alcohol-associated Hepatitis

Global AlcHep, a big data network, is a global initiative that aims at developing a large multinational de-identified clinical database in alcohol-associated hepatitis . If you need RedCap access, please contact us at the e-mail: globalalchep@gmail.com.

LEARN MORE
REDCAP ACCESS

Purpose

Our aim is to create a centralized database registry that captures the main demographic and clinical characteristics of patients with Alcohol-associated Liver Disease and Alcohol-associated Hepatitis at a global level, enabling large-scale studies to identify the main trends and determinants of clinical outcomes. Read the letters below for more information.

INVITATION LETTER

Real-time Updates

Know the latest news and current situation of participant centers and patients included in our large cohorts.

Our Research

Access to our latest research and reviews in alcohol-associated liver disease and alcohol-associated hepatitis.

Contact Us

You can join the team today! Contact us to obtain RedCap access and the Institutional Review Board documentation.

Our latest publications:

Slide 1
Alcohol-Associated Hepatitis

Ramon Bataller, M.D., Ph.D., Juan Pablo Arab, M.D., and Vijay H. Shah, M.D.

Read the article
Clinical, histological and molecular profiling of different stages of alcohol-related liver disease
Clinical, histological and molecular profiling of different stages of alcohol-related liver disease

Meritxell Ventura-Cots, Josepmaria Argemi, Patricia D Jones et al.

Read the article
Slide 1
The MELD Score Is Superior to the Maddrey Discriminant Function Score to Predict Short-Term Mortality in Alcohol-Associated Hepatitis: A Global Study

Morales-Arráez, Ventura-Cots, Altamirano, Abraldes, et al.

Read the article
Slide 1
Impact of Public Health Policies on Alcohol-Associated Liver Disease in Latin America: An Ecological Multinational Study

Luis Antonio Díaz, Francisco Idalsoaga, Eduardo Fuentes-López, Andrea Márquez-Lomas et al.

Read the article
Slide 1
Identification of optimal therapeutic window for steroid use in severe alcohol-associated hepatitis: A worldwide study

Juan Pablo Arab, Luis Antonio Diaz, Natalia Baeza, Francisco Idalsoaga et al.

Read the article
previous arrow
next arrow

“What is the point of being alive if you don’t at least try to do something remarkable?”

RAMON BATALLER

“Although alcohol is a well-known cause of liver disease, there are many things to discover yet”

JUAN PABLO ARAB